SCHEMBL1986758

SCHEMBL1986758

Cn1ncc2c1CCCC2=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLK1 P53350 1/20 1.00
CSNK2A1 P68400 1/20 1.00
PLK3 Q9H4B4 1/20 1.00
HTT P42858 1/20 0.54
ELANE P08246 3/20 0.53
CA1 P00915 8/20 0.47
CA2 P00918 7/20 0.47
CA4 P22748 7/20 0.47
CA9 Q16790 6/20 0.47
CYP11B2 P19099 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
ALDH1A1 P00352 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
POLB P06746 1/20 0.39
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
PABPC1 P11940 1/20 0.38
TSHR P16473 1/20 0.38
HIF1A Q16665 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3142557 0.96 PLK1 (0.93) PLK1CSNK2A1PLK3HTTELANE
SCHEMBL22980483 0.88 PLK1 (0.79) PLK1CSNK2A1PLK3HTTELANE
SCHEMBL9533936 0.86 PLK1 (0.74) PLK1CSNK2A1PLK3HTTELANE
SCHEMBL9534422 0.80 PLK1 (0.65) PLK1CSNK2A1PLK3HTTELANE
SCHEMBL1543821 0.78 CSNK2A1 (0.64) PLK1CSNK2A1PLK3HTTELANE
SCHEMBL9149384 0.78 PLK1 (0.63) PLK1CSNK2A1PLK3HTTELANE
SCHEMBL22349291 0.77 PLK1 (0.62) PLK1CSNK2A1PLK3HTTELANE
SCHEMBL366643 0.77 PLK1 (0.62) PLK1CSNK2A1PLK3HTTELANE
SCHEMBL9535703 0.77 PLK1 (0.61) PLK1CSNK2A1PLK3CYP11B2ALDH1A1
SCHEMBL9142953 0.77 PLK1 (0.62) PLK1CSNK2A1PLK3HTTELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 108 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250109139-A1 TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF CENTER FOR EXCELLENCE IN MOLECULAR CELL SCIENCE, CHINESE ACADEMY OF SCIENCES (CN) 2025-04-03 US disclosed
CN-112424195-B Fused lactam derivatives 住友制药株式会社 2025-03-25 CN disclosed
US-20250084090-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY Sumitomo Pharma Co., Ltd. (JP) 2025-03-13 US disclosed
US-12180213-B2 Substituted pyrazoles showing serotonin 5-HT receptor activity SUMITOMO PHARMA CO. LTD. (JP) 2024-12-31 US disclosed
US-20230276802-A1 Method for Controlling Hematophagous or Sap-Feeding Arthropods BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSTIY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2023-09-07 US disclosed
WO-2023143393-A1 TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海科技大学 2023-08-03 WO disclosed
CN-116514824-A Tri-ring compound, preparation method and application thereof 上海科技大学 2023-08-01 CN disclosed
US-11632953-B2 Method for controlling hematophagous or sap-feeding arthropods BOARD OF SUPERVISORS OF LOUISIANA STATE UNIVERSITY AND AGRICULTURAL AND MECHANICAL COLLEGE (US) 2023-04-25 US disclosed
US-20230008875-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY Sumitomo Pharma Co., Ltd. (JP) 2023-01-12 US disclosed
US-20230008875-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY Sumitomo Pharma Co., Ltd. (JP) 2023-01-12 US disclosed
WO-2005063764-A2 FUSED PYRROLOCARBAZOLES AND METHODS FOR THE PREPARATION THEREOF CEPHALON, INC. (US) 2005-07-14 WO disclosed
EP-0590558-B1 Pharmaceutical composition containing 1,5,6,7-tetrahydro-4H-indazol-4-ones,new 1,5,6,7-tetrahydro-4H-indazol-4-ones and process for their manufacture THOMAE GMBH DR K (DE) 1995-12-06 EP disclosed
US-5468766-A Analgesics, antipyretics, antiphlogistics DR. KARL THOMAE GMBH (DE) 1995-11-21 US disclosed
EP-0276833-B1 Dipyrazoles useful as bronchodilators MERRELL DOW PHARMA (US) 1995-02-15 EP disclosed
EP-0590558-A1 Pharmaceutical composition containing 1,5,6,7-tetrahydro-4H-indazol-4-ones,new 1,5,6,7-tetrahydro-4H-indazol-4-ones and process for their manufacture Dr. Karl Thomae GmbH (DE) 1994-04-06 EP disclosed
EP-0276834-B1 Cycloalkane [1,2-c:4,3-c'] dipyrazoles MERRELL DOW PHARMACEUTICALS INC. (US) 1993-06-02 EP disclosed
EP-0276833-A2 Dipyrazoles useful as bronchodilators MERRELL DOW PHARMACEUTICALS INC. (US) 1988-08-03 EP disclosed
EP-0276834-A1 Cycloalkane [1,2-c:4,3-c'] dipyrazoles MERRELL DOW PHARMACEUTICALS INC. (US) 1988-08-03 EP disclosed
US-4734429-A Cycloalkane[1,2-c:4,3-c']dipyrazoles and their use as bronchodilators MERRELL DOW PHARMACEUTICALS INC. (US) 1988-03-29 US disclosed
US-4734430-A Dipyrazoles and their use as bronchodilators MERRELL DOW PHARMACEUTICALS INC. (US) 1988-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250084090-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY HTR1A, HTR5A, TPH1 PLK1 1447/4885CSNK2A1 1326/4885PLK3 2881/4885
US-12180213-B2 Substituted pyrazoles showing serotonin 5-HT receptor activity HTR5A, HTR1A, TPH1 PLK1 1277/4885CSNK2A1 1289/4885PLK3 988/4885
US-11632953-B2 Method for controlling hematophagous or sap-feeding arthropods KCNN1, KCNN2, KCNN3 PLK1 1496/4885CSNK2A1 3338/4885PLK3 3083/4885
US-20250109139-A1 TRICYCLIC COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF PARK7, HADH, BDNF PLK1 2719/4885CSNK2A1 3439/4885PLK3 4064/4885
US-20230008875-A1 SUBSTITUTED LACTAMS SHOWING SEROTONIN 5-HT RECEPTOR ACTIVITY HTR1A, HTR5A, TPH1 PLK1 1447/4885CSNK2A1 1326/4885PLK3 2881/4885
US-20230276802-A1 Method for Controlling Hematophagous or Sap-Feeding Arthropods KCNN1, KCNN2, KCNN3 PLK1 1496/4885CSNK2A1 3338/4885PLK3 3083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.